Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Prognostic factors in IgG4-related disease: a long-term monocentric Chinese cohort study.
Clin Rheumatol. 2021 Jun;40(6):2293-2300. doi: 10.1007/s10067-020-05484-8. Epub 2020 Nov 5.
Clin Rheumatol. 2021.
PMID: 33151477
In vitro IL-6/IL-6R Trans-Signaling in Fibroblasts Releases Cytokines That May Be Linked to the Pathogenesis of IgG4-Related Disease.
Zongfei J, Rongyi C, Xiaomeng C, Lili M, Lingying M, Xiufang K, Xiaomin D, Zhuojun Z, Huiyong C, Ying S, Lindi J.
Zongfei J, et al. Among authors: lingying m.
Front Immunol. 2020 Jul 8;11:1272. doi: 10.3389/fimmu.2020.01272. eCollection 2020.
Front Immunol. 2020.
PMID: 32733444
Free PMC article.
Item in Clipboard
Effect of hydroxychloroquine on angiographic progression in routine treatment of Takayasu arteritis.
Rongyi C, Zongfei J, Jiang L, Sifan W, Lingying M, Ying S, Wenshu Y, Xiaomeng C, Xiufang K, Xiaomin D, Lili M, Yanshan L, Lindi J.
Rongyi C, et al. Among authors: lingying m.
Mod Rheumatol. 2021 Nov;31(6):1135-1141. doi: 10.1080/14397595.2021.1879347. Epub 2021 Apr 15.
Mod Rheumatol. 2021.
PMID: 33497271
Item in Clipboard
Improved clinical outcomes of tocilizumab versus cyclophosphamide for IgG4-related disease: insights from a prospective IgG4-related disease registry.
Zongfei J, Lijuan Z, Ying S, Dongmei L, Sifan W, Xiufang K, Lingying M, Yun L, Lili M, Huiyong C, Lindi J.
Zongfei J, et al. Among authors: lingying m.
Ther Adv Chronic Dis. 2021 Jun 30;12:20406223211028776. doi: 10.1177/20406223211028776. eCollection 2021.
Ther Adv Chronic Dis. 2021.
PMID: 34262681
Free PMC article.
Item in Clipboard
Clinical and pathological predictors of relapse in IgG4-related disease.
Zongfei J, Lingli C, Ying S, Lingying M, Lijuan Z, Dongmei L, Xiaomin D, Yingyong H, Huiyong C, Lili M, Lindi J.
Zongfei J, et al. Among authors: lingying m.
Arthritis Res Ther. 2022 May 11;24(1):106. doi: 10.1186/s13075-022-02792-z.
Arthritis Res Ther. 2022.
PMID: 35546243
Free PMC article.
Item in Clipboard
High level of serum complement 3 is a risk factor for vascular stenosis progression in TA patients receiving tocilizumab: a prospective observational study.
Rongyi C, Xiaojuan D, Jinghua W, Lingying M, Xiaomin D, Lili M, Huiyong C, Lindi J, Ying S.
Rongyi C, et al. Among authors: lingying m.
Arthritis Res Ther. 2023 Aug 2;25(1):137. doi: 10.1186/s13075-023-03106-7.
Arthritis Res Ther. 2023.
PMID: 37533103
Free PMC article.
Item in Clipboard
Cite
Cite